Work

Sa1751 THE ATP CITRATE LYASE (ACLY) AS AN IMMUNOMETABOLIC TARGET TO THERAPEUTICALLY MODULATE THE COLITOGENIC CAPACITY OF INTESTINAL T CELLS IN IBD